Maria Korinek-Paulke

Vienna, 1010, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities-An Agent-Based Modeling Evaluation.

Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities-An Agent-Based Modeling Evaluation.

Journal: Vaccines

Published: April 02, 2021

One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary series.

One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary series.

Journal: Journal of travel medicine

Published: February 18, 2016

Short-Term Immunogenicity and Safety of an Accelerated Pre-Exposure Prophylaxis Regimen With Japanese Encephalitis Vaccine in Combination With a Rabies Vaccine: A Phase III, Multicenter, Observer-Blind Study.

Short-Term Immunogenicity and Safety of an Accelerated Pre-Exposure Prophylaxis Regimen With Japanese Encephalitis Vaccine in Combination With a Rabies Vaccine: A Phase III, Multicenter, Observer-Blind Study.

Journal: Journal of travel medicine

Published: May 23, 2015

Genetic Variation of Bordetella pertussis in Austria.

Genetic Variation of Bordetella pertussis in Austria.

Journal: PloS one

Published: April 30, 2015

Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.

Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.

Journal: Vaccine

Published: February 19, 2015

Rotavirus vaccines: a story of success.

Rotavirus vaccines: a story of success.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: December 19, 2014

Evaluation of rabies immunogenicity and tolerability following a purified chick embryo cell rabies vaccine administered concomitantly with a Japanese encephalitis vaccine.

Evaluation of rabies immunogenicity and tolerability following a purified chick embryo cell rabies vaccine administered concomitantly with a Japanese encephalitis vaccine.

Journal: Travel medicine and infectious disease

Published: November 03, 2014

The burden of pneumococcal meningitis in Austrian children between 2001 and 2008.

The burden of pneumococcal meningitis in Austrian children between 2001 and 2008.

Journal: European journal of pediatrics

Published: September 05, 2013

Characteristics of invasive pneumococcal disease in hospitalized children in Austria.

Characteristics of invasive pneumococcal disease in hospitalized children in Austria.

Journal: European journal of pediatrics

Published: August 04, 2013

Tick-borne encephalitis (TBE) and hepatitis B nonresponders feature different immunologic mechanisms in response to TBE and influenza vaccination with involvement of regulatory T and B cells and IL-10.

Tick-borne encephalitis (TBE) and hepatitis B nonresponders feature different immunologic mechanisms in response to TBE and influenza vaccination with involvement of regulatory T and B cells and IL-10.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: July 23, 2013

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.

Journal: The Lancet. Infectious diseases

Published: May 14, 2013

Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria.

Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria.

Journal: Vaccine

Published: January 30, 2013

Showing 1-12 of 20

Last Updated: 09/26/2026